title: Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas.
authors.forename: Jianming
authors.initials: J
authors.lastname: Ying
authors.forename: Gopesh
authors.initials: G
authors.lastname: Srivastava
authors.forename: Zifen
authors.initials: Z
authors.lastname: Gao
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Zhang
authors.forename: Paul
authors.initials: P
authors.lastname: Murray
authors.forename: Richard
authors.initials: R
authors.lastname: Ambinder
authors.forename: Qian
authors.initials: Q
authors.lastname: Tao
mesh_terms: D001483:Base Sequence; D002277:Carcinoma / Q000235:genetics*; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000235:genetics*; D019175:DNA Methylation; D017931:DNA Primers; D006801:Humans; D008223:Lymphoma / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014407:Tumor Cells, Cultured
chemical_list: C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D017931:DNA Primers